Tumor-Treg-Targeting at a glance
The general aim of Tumor Treg Targeting is to train early stage researchers (ESR) at established academic and private institutions through three research objectives:
To develop novel biologicals that can target cell populations – such as cancerous cells or specific subtypes of leukocytes – with unprecedented specificity.
To specifically engage particular cell types of the innate immune system within tumours with applied biologicals in a directed fashion.
To target known immune-modulating cytokines or known check-point inhibitors directly into established tumours.